Effects of theophylline in p-chlorophenylalanine-treated mice in a light/dark test

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 8, 1996, Pages 513-520

  Imaizumi, Masahiro ^a   Miyazaki, Shuichi ^a   Onodera, Kenji ^b  

^a YAMASA CORPORATION   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

anxiety; do pamine; light dark test; noradrenaline; p chlorophenylalanine; serotonin; theophylline; xanthine

Indexed keywords

FENCLONINE; NORADRENALIN; SEROTONIN; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DARKNESS; LABORATORY TEST; LIGHT; MALE; MOUSE; NONHUMAN; SEROTONINERGIC SYSTEM;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DARKNESS; FENCLONINE; LIGHT; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; SEROTONIN AGENTS; THEOPHYLLINE;

EID: 0030471890     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Imaizumi, M., Miyazaki, S., Onodera, K. Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors. Meth Find Exp Clin Pharmacol 1994, 16: 639-44.
2. Baldwin, H.A., File, S.E. Caffeine-induced anxiogenesis: The role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav 1989, 32: 181-6.
3. Baldwin, H.A., Johnston, A.L., File, S.E. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol 1989, 159: 211-5.
4. Boulenger, J.-P., Salem, N. Jr., Marangos, P.J., Uhde, T.W. Plasma adenosine levels: Measurement in humans and relationship to anxiogenic effects of caffeine. Psychiatr Res 1987, 21: 247-55.
5. Greden, J.F., Fontaine, P., Lubetsky, M., Chamberlin, K. Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatry 1978, 135: 963-6.
6. Griffiths, R.R., Woodson, P.P. Reinforcing properties of caffeine: Studies in humans and laboratory animals. Pharmacol Biochem Behav 1988, 29: 419-27.
7. Snyder, S.H., Sklar, P. Behavioral and molecular actions of caffeine: Focus on adenosine. J Psychiatr Res 1984, 18: 91-106.
8. Imaizumi, M., Miyazaki S., Onodera, K. Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice. Meth Find Exp Clin Pharmacol 1994, 16: 717-21.
9. Kitatani, T., Watanabe, Y., Shibuya, T. Different effects of methylxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model. Pharmacol Biochem Behav 1993, 44: 457-61.
10. Barrett, J.E., Vanover, K.E. 5-HT receptors as targets for the development of novel anxiolytic drugs: Models, mechanisms and future directions. Psychopharmacology 1993, 112: 1-12.
11. Handley, S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 1995, 66: 103-48.
12. Handley, S.L., McBlane, J.W. 5HT drugs in animal models of anxiety. Psychopharmacology 1993, 112: 13-20.
13. Nisikawa, T., Scatton, B. Neuroanatomical site of the inhibitory influence of anxiolytic drugs on central serotonergic transmission. Brain Res 1986, 371: 123-32.
14. Pratt, J.A. The neuronal basis of anxiety. Pharmacol Ther 1992, 55: 149-81.
15. 1A receptor-related anxiolytics. Trends Pharmacol Sci 1987, 8: 432-37.
16. Griebel, G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research. Pharmacol Ther 1995, 65: 319-95.
17. Koe B.K., Weissman, A. p-Chlorophenylalanine: A specific depletor of brain serotonin. J Pharmacol Exp Ther 1966, 154: 499-516.
18. Miller, F.P., Cox, R.H. Jr., Snodgrass, W.R., Maickel. R.P. Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem Pharmacol 1970, 19: 435-42.
19. Imaizumi, M., Suzuki, T., Machida, H., Onodera, K. A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Jpn J Psychopharmacol 1994, 14: 83-91.
20. 3-receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sci 1993, 53: 1675-83.
21. Ida, Y., Tanaka, M., Tsuda, A., Tsujimaru, S., Nagasaki, N. Attenuating effect of diazepam on stress-induced increase in noradrenaline turnover in specific brain regions of rats: Antagonism by Ro 15-1788. Life Sci 1985, 37: 2491-8.
22. Barnes, N.M., Cheng, C.H.K., Costall, B., Ge, J., Kelly, M.E., Naylor, R.J. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agent in a mouse model. Eur J Pharmacol 1992, 218: 91-100.
23. Barnes, N.M., Costall, B., Ge, J., Kelly, M.E., Naylor, R.J. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour. Eur J Pharmacol 1992, 218: 15-25.
24. File, S.E., Hyde, J.R.G. The effects of p-chlorophenylalanine and ethanolamine-O-sulphate in an animal test of anxiety. J Pharm Pharmacol 1977, 29: 735-8.
25. Geller, I., Blum, K. The effects of 5-HTP on para-chlorophenylalanine (p-CPA) attenuation of "conflict" behavior. Eur J Pharmacol 1970, 9: 319-24.
26. Robichaud, R.C., Sledge, K.L. The effects of p-chlorophenylalanine on experimentally induced conflict in the rat. Life Sci 1969, 8: 965-9.
27. Blakely, T.A., Parker, L.F. The effects of para-chlorophenylalanine on experimentally induced conflict behavior. Pharmacol Biochem Behav 1973, 1: 609-13.
28. 2 receptor ligands modulate the bahaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 1994, 49: 985-95.
29. Salamone, J.D., Cousins, M.S., Bucher, S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 1994, 65: 221-9.
30. Kelley, A.E., Cador, M., Stinus, L. Exploration and its measurement. A psychopahrmacological perspective. In: Neuromethods 13. Psychopharmacology. Boulton, A.A., Baker G.A., Greenshaw, A.J. (Eds.). Humana Press: Clifton 1989, 95-144.
31. 3 receptors. Eur J Pharmacol 1994, 263: 235-43.
32. Imaizumi, M. Animal models oJ anxiety based on exploratory behavior in rodents. Meth Find Exp Clin Pharmacol 1996, 18 (Suppl. A): 31-8.